Medrio Revenue and Competitors

Welcome to Medrio's LinkedIn page! Follow us for company news, product updates, industry insights, and more.\n\nMedrio delivers integrated eClinical software designed specifically for pharmaceutical, biotech, medical device, diagnostics, and animal health markets. Our innovative electronic data capture (EDC), eSource, eConsent, and ePRO products empower our customers to reduce costs and timelines so that CROs can increase their trial volume and sponsors can bring products to regulatory submission faster. \n\nSince our founding in 2005 as the first cloud-based EDC system, we’ve become known throughout the market for our easy-to-use solutions and for delivering speed and simplicity to our customers’ clinical trials. Medrio users can build their databases in an average of 2.8 weeks with no programming required, make mid-study changes with just a few clicks of a mouse, and much more. Our innovative software, as well as the robust and flexible training, onboarding, and support resources we provide our customers, have earned us a 98% customer satisfaction rating. \n\nMedrio is the market leader in early phase trials and serves over 600 customers globally, with headquarters in San Francisco and offices across the United States, Europe, and Asia. \n\nVisit medrio.com for more information.